Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4071172)

Published in Korean J Physiol Pharmacol on June 12, 2014

Authors

Gautamjeet S Mangat1, Amteshwar S Jaggi1, Nirmal Singh1

Author Affiliations

1: Pharmacology Division, Department of Pharmaceutical Sciences and Drug Research, Faculty of Medicine, Punjabi University, Patiala (Punjab) 147002, India.

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem (1979) 41.65

Improved method for the determination of blood glutathione. J Lab Clin Med (1963) 13.04

The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement (2013) 7.69

Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem (2002) 1.43

Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. J Alzheimers Dis (2010) 1.21

Hippocampal long-term depression mediates spatial reversal learning in the Morris water maze. Neuropharmacology (2012) 1.16

Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol (2011) 1.11

Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J Cereb Blood Flow Metab (2013) 1.04

Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci (2012) 0.97

Vascular dementia. J Neurol Sci (2012) 0.96

Interventions targeting pain or behaviour in dementia: a systematic review. Ageing Res Rev (2013) 0.95

Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91

Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology (Berl) (2011) 0.90

Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property. J Renin Angiotensin Aldosterone Syst (2012) 0.90

Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats. PLoS One (2013) 0.88

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med (2013) 0.88

Water extract of Triticum aestivum L. and its components demonstrate protective effect in a model of vascular dementia. J Med Food (2010) 0.87

Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci (2012) 0.86

Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice. Biochim Biophys Acta (2013) 0.86

Up-regulation of COX-2/PGE2 by endothelin-1 via MAPK-dependent NF-κB pathway in mouse brain microvascular endothelial cells. Cell Commun Signal (2013) 0.86

Endothelin receptor antagonists: potential in Alzheimer's disease. Pharmacol Res (2010) 0.85

Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing (2013) 0.85

Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. Seizure (2012) 0.84

Effects of different exercise protocols on ethanol-induced spatial memory impairment in adult male rats. Alcohol (2013) 0.84

Neuroprotective Effects of AMP-Activated Protein Kinase on Scopolamine Induced Memory Impairment. Korean J Physiol Pharmacol (2013) 0.83

Reduction of Long-Term Care Dependence After an 8-Year Primary Care Prevention Program for Stroke and Dementia: The INVADE Trial. J Am Heart Assoc (2012) 0.83

Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. BMC Pharmacol (2008) 0.83

Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors. J Mol Cell Cardiol (2013) 0.82

Estradiol prevents homocysteine-induced endothelial injury in male rats. Cardiovasc Res (2002) 0.82

Constriction of retinal arterioles to endothelin-1: requisite role of rho kinase independent of protein kinase C and L-type calcium channels. Invest Ophthalmol Vis Sci (2012) 0.82

Palm tocotrienol-rich fraction improves vascular proatherosclerotic changes in hyperhomocysteinemic rats. Evid Based Complement Alternat Med (2013) 0.82

Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.82

Phellodendron amurense and Its Major Alkaloid Compound, Berberine Ameliorates Scopolamine-Induced Neuronal Impairment and Memory Dysfunction in Rats. Korean J Physiol Pharmacol (2012) 0.81

Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Br J Pharmacol (2009) 0.81

Diagnosing and managing vascular dementia. Practitioner (2012) 0.80

Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke. Neuropharmacology (2012) 0.80

Contradictory Effects of Superoxide and Hydrogen Peroxide on KCa3.1 in Human Endothelial Cells. Korean J Physiol Pharmacol (2013) 0.80

Blood pressure, smoking and alcohol use, association with vascular dementia. Exp Gerontol (2012) 0.80

Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype. J Alzheimers Dis (2013) 0.80

Endothelin receptor antagonists: a place in the management of essential hypertension? Nephrol Dial Transplant (2012) 0.80

Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.80

Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol (2010) 0.79

Asymmetric dimethylarginine: a possible link between vascular disease and dementia. Curr Alzheimer Res (2013) 0.79

Safe treatment of pulmonary hypertension with bosentan in a patient with moyamoya disease and cerebral ischemia. J Child Neurol (2009) 0.79

Mild hyperhomocysteinemia reduces the activity and immunocontent, but does not alter the gene expression, of catalytic α subunits of cerebral Na+,K+-ATPase. Mol Cell Biochem (2013) 0.78

Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia. Clin Exp Pharmacol Physiol (2013) 0.78

Genistein attenuates vascular endothelial impairment in ovariectomized hyperhomocysteinemic rats. J Biomed Biotechnol (2012) 0.78

Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats. Pharmacol Biochem Behav (2012) 0.77

Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin. J Pharmacol Exp Ther (2013) 0.77

Potential contribution of SOCC to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Brain Res (2013) 0.77

Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology (Berl) (2012) 0.77

[Prevention of vascular dementia. Evidence and practice]. Internist (Berl) (2012) 0.76

Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons. Exp Brain Res (2013) 0.76

Changes in endothelin receptor type B and neuronal nitric oxide synthase in puromycin aminonucleoside-induced nephrotic syndrome. Korean J Physiol Pharmacol (2010) 0.76